Mustafa Barbhuiya
Baystate Health, Quest Diagnostics Inc, Penn State College of Medicine
0000-0002-8046-5064
About
Dr. Mustafa Barbhuiya is currently the Medical Director of Clinical Chemistry and Point of Care Testing at the Department of Pathology, University of Massachusetts Medical School- Baystate Health, Springfield, MA. He completed the Clinical Chemistry Fellowship (2018-2020) at the Department of Pathology and Laboratory Medicine, Penn State University College of Medicine, Hershey. Dr. Barbhuiya earned a Doctorate in Biochemistry (2013) from Jiwaji University, Gwalior, India and subsequently completed postdoctoral studies (2013-2018) from Johns Hopkins University School of Medicine, Baltimore, USA. He is broadly trained in molecular pathology, clinical biochemistry, medical laboratory sciences, cancer epidemiology, cancer biomarkers, next generation sequencing and mass spectrometry. He is also ASCP BOC certified in Molecular Biology and Medical Laboratory Sciences. He practices academic laboratory medicine and clinical laboratory management. Last year he was selected as one of the American Society for Clinical Pathologists’ (ASCP’s) 40 Under Forty 2019. The ‘ASCP 40 under forty’ program recognizes members under the age of 40 for their achievements and leadership qualities that are making an impact on pathology and laboratory medicine. Dr. Barbhuiya established a non-profit Foundation for Advancement of Essential Diagnostics (FAED), Guwahati, India, in 2018 and subsequently in Pennsylvania, USA in 2020. The overall goal of this foundation is to promote and further augment the ‘essential diagnostics list’ published by World Health Organization in context to South and South East Asia. FAED aims to provide framework for a strong and functional evidence-based laboratory medicine regulatory system in south-east Asia to maintain and sustain the quality assurance and continuous improvement in the practice of laboratory medicine in low-resource settings. The Foundation for Advancement of Essential Diagnostics (FAED) also envisions to collaborate with Pan-American Health Organization to expand the ‘essential diagnostics list’ in context to Latin American continent in coming years. Furthermore, FAED aims to work towards providing essential diagnostics services for uninsured and under-insured American people who are denied utilizing these essential health services due to lack of insurance coverage.
Employment
-
Baystate Health Medical Director of Clinical Chemistry and Point of Care Testing2021 - Present
-
Quest Diagnostics Inc Associate Scientific Director2020 - 2021
-
Penn State College of Medicine Clinical Chemistry Fellow2018 - 2020
-
Johns Hopkins Medicine Postdoctoral Fellow2013 - 2018
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (27)
- A Thirteen-Year-Old Boy with Rashes and Bumps on Arms and Legs Save
- Automated Measurement of Plasma Cell-Free Hemoglobin Using the Hemolysis Index Check Function Save
- MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity. Save
- Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression Save
- Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate Save
- Abstracts of Presentations at the Association of Clinical Scientists 139th Meeting Hershey, PA, May 15-18, 2019. Save
- PIM1 kinase promotes gallbladder cancer cell proliferation via inhibition of proline-rich Akt substrate of 40 kDa (PRAS40). Save
- O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis. Save
- Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays. Save
- Discovery of noncanonical translation initiation sites through mass spectrometric analysis of protein N termini. Save